Parents' anger at latest Strep B test snub

Frustrated parents have criticised health bosses after plans to introduce new testing for a deadly infection in newborns were scrapped.

Group B Streptococcus (Group B Strep or GBS) is a bacterial infection that is harmless to the 25 per cent of pregnant women who carry it, but can be transmitted from mother to baby in the birth canal and is the most common cause of life-threatening infection in babies, causing lethal illnesses such as meningitis, blood poisoning or pneumonia.

If detected, pregnant mothers can be given antibiotics during labour to dramatically reduce the risk of infection to their babies.

However, unlike many other countries, a specific test for GBS is still not available in the UK, with the ‘general purpose’ test currently used within the NHS failing to identify the infection in 40 per cent of cases.

The Department of Health had planned on making a GBS-specific swab accessible from the start of the year but, to the anger of parents and campaigners, has now performed a dramatic last minute U-turn.

Last February, Adrian and Gillian Neill’s daughter Maisy, now ten and a half months, was rushed into hospital with the infection and meconium aspiration – ingestion of first faeces – which led to a collapsed lung.

Although Maisy has made a full recovery, Mr Neill, of Deerleap Way, Braintree, is frustrated that better testing continues to be overlooked.

Comments (1)

Please log in to enable comment sorting

3:54pm Thu 2 Jan 14

OMPITA [Intl] says...

Well come on Mr Journalist, tell us why there has been a 'U' turn.

Is it a matter budgeting provisions? Is it perhaps uncertainty about its efficacy or safety?

What does it cost? Is it something that mothers-to-be can elect to pay for privately?

There are so many obvious questions relating to this story. Have none of them been investigated?

Not a very good start for 2014 is it?
Well come on Mr Journalist, tell us why there has been a 'U' turn. Is it a matter budgeting provisions? Is it perhaps uncertainty about its efficacy or safety? What does it cost? Is it something that mothers-to-be can elect to pay for privately? There are so many obvious questions relating to this story. Have none of them been investigated? Not a very good start for 2014 is it? OMPITA [Intl]

Comments are closed on this article.

click2find

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree